$2.45 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 124 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 90.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HUM | Buy | HUMANA INCcall | $144,282,000 | +399.2% | 1,280,000 | +357.1% | 5.89% | +293.5% |
| DENDREON CORPnote 2.875% 1/1 | $133,789,000 | +15.0% | 183,660,000 | 0.0% | 5.46% | -9.4% | ||
| FLML | Buy | FLAMEL TECHNOLOGIES SAsponsored adr | $70,464,000 | +102.0% | 5,258,475 | +21.3% | 2.88% | +59.2% |
| AUXL | Sell | AUXILIUM PHARMACEUTICALS INC | $69,763,000 | -18.2% | 2,566,705 | -37.6% | 2.85% | -35.5% |
| LH | New | LABORATORY CORP AMER HLDGS | $69,699,000 | – | 709,689 | +100.0% | 2.85% | – |
| DRNA | New | DICERNA PHARMACEUTICALS INC | $68,607,000 | – | 2,428,569 | +100.0% | 2.80% | – |
| QCOR | Sell | QUESTCOR PHARMACEUTICALS INC | $67,518,000 | -17.7% | 1,039,865 | -31.0% | 2.76% | -35.1% |
| ASPX | New | AUSPEX PHARMACEUTICALS INC | $61,181,000 | – | 1,988,990 | +100.0% | 2.50% | – |
| VOLCANO CORPORATIONnote 1.750%12/0 | $59,767,000 | +0.0% | 60,500,000 | 0.0% | 2.44% | -21.2% | ||
| ARRY | Buy | ARRAY BIOPHARMA INC | $57,367,000 | +1.9% | 12,205,673 | +8.6% | 2.34% | -19.7% |
| ITMN | New | INTERMUNE INC | $53,015,000 | – | 1,583,942 | +100.0% | 2.16% | – |
| INFI | Buy | INFINITY PHARMACEUTICALS INC | $52,839,000 | -3.9% | 4,444,027 | +11.6% | 2.16% | -24.3% |
| ABBV | New | ABBVIE INC | $52,685,000 | – | 1,025,000 | +100.0% | 2.15% | – |
| Sell | INTERMUNE INCnote 2.500% 9/1 | $51,373,000 | +38.2% | 40,295,000 | -3.1% | 2.10% | +8.9% | |
| QCOR | Buy | QUESTCOR PHARMACEUTICALS INCcall | $48,698,000 | +78.9% | 750,000 | +50.0% | 1.99% | +41.0% |
| NXTM | Sell | NXSTAGE MEDICAL INC | $48,427,000 | -13.1% | 3,801,175 | -31.8% | 1.98% | -31.5% |
| INTEGRA LIFESCIENCES HLDGS Cnote 1.625%12/1 | $43,698,000 | -1.8% | 41,523,000 | 0.0% | 1.78% | -22.6% | ||
| INSM | Buy | INSMED INC | $38,387,000 | +114.6% | 2,016,147 | +91.6% | 1.57% | +69.0% |
| HOLOGIC INCdebt 2.000% 3/0 | $38,347,000 | +0.0% | 37,516,000 | 0.0% | 1.57% | -21.1% | ||
| New | AMAG PHARMACEUTICALS INCnote 2.500% 2/1 | $34,986,000 | – | 34,520,000 | +100.0% | 1.43% | – | |
| DYAX | Buy | DYAX CORP | $34,003,000 | +34.4% | 3,786,478 | +12.8% | 1.39% | +5.9% |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $33,648,000 | +224.4% | 3,986,760 | +126.4% | 1.37% | +155.9% |
| ITMN | New | INTERMUNE INCcall | $33,470,000 | – | 1,000,000 | +100.0% | 1.37% | – |
| ATRS | Sell | ANTARES PHARMA INC | $33,210,000 | -26.8% | 9,488,461 | -6.4% | 1.36% | -42.3% |
| TRNX | Buy | TORNIER N V | $32,977,000 | +16.2% | 1,554,075 | +2.9% | 1.35% | -8.4% |
| UAM | Buy | UNIVERSAL AMERN CORP NEW | $32,529,000 | -3.1% | 4,600,993 | +0.0% | 1.33% | -23.7% |
| Buy | ACCURAY INCnote 3.750% 8/0 | $30,767,000 | +29.7% | 25,700,000 | +21.2% | 1.26% | +2.2% | |
| AIRM | Buy | AIR METHODS CORP | $29,522,000 | +106.6% | 552,544 | +125.3% | 1.20% | +62.8% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $28,923,000 | +27.1% | 5,406,110 | +24.2% | 1.18% | +0.2% |
| MCK | New | MCKESSON CORP | $28,781,000 | – | 163,000 | +100.0% | 1.18% | – |
| MDT | New | MEDTRONIC INC | $28,555,000 | – | 464,000 | +100.0% | 1.17% | – |
| MRK | Sell | MERCK & CO INC NEW | $27,091,000 | -25.3% | 477,200 | -34.2% | 1.11% | -41.2% |
| AGN | Buy | ALLERGAN INC | $26,760,000 | +58.5% | 215,636 | +41.9% | 1.09% | +24.9% |
| Buy | ARRAY BIOPHARMA INCnote 3.000% 6/0 | $26,665,000 | +11.2% | 26,000,000 | +13.0% | 1.09% | -12.3% | |
| GEVA | New | SYNAGEVA BIOPHARMA CORP | $26,358,000 | – | 317,678 | +100.0% | 1.08% | – |
| DGX | New | QUEST DIAGNOSTICS INC | $25,502,000 | – | 440,303 | +100.0% | 1.04% | – |
| DVA | Sell | DAVITA HEALTHCARE PARTNERS I | $23,961,000 | -22.0% | 348,011 | -28.2% | 0.98% | -38.6% |
| KERX | Sell | KERYX BIOPHARMACEUTICALS INC | $23,909,000 | +24.5% | 1,403,105 | -5.4% | 0.98% | -1.9% |
| XNPT | Buy | XENOPORT INC | $22,669,000 | +6.0% | 4,384,797 | +17.9% | 0.92% | -16.5% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $20,276,000 | – | 302,000 | +100.0% | 0.83% | – |
| PTLA | Sell | PORTOLA PHARMACEUTICALS INC | $19,939,000 | -6.2% | 769,848 | -6.8% | 0.81% | -26.1% |
| HZNP | Sell | HORIZON PHARMA INC | $19,821,000 | -43.9% | 1,310,930 | -71.7% | 0.81% | -55.8% |
| INTERMUNE INCnote 2.500%12/1 | $19,618,000 | +90.7% | 7,500,000 | 0.0% | 0.80% | +50.3% | ||
| RNA | Buy | PROSENSA HLDG N V | $18,080,000 | +24.1% | 3,211,372 | +2.9% | 0.74% | -2.3% |
| OFIX | New | ORTHOFIX INTL N V | $17,832,000 | – | 591,431 | +100.0% | 0.73% | – |
| ZGNX | Buy | ZOGENIX INC | $17,567,000 | +98.7% | 6,174,809 | +140.3% | 0.72% | +56.6% |
| MOH | Sell | MOLINA HEALTHCARE INC | $16,954,000 | -24.4% | 451,391 | -30.0% | 0.69% | -40.4% |
| OVAS | Buy | OVASCIENCE INC | $14,953,000 | +170.2% | 1,672,549 | +176.2% | 0.61% | +112.5% |
| PETX | New | ARATANA THERAPEUTICS INC | $14,642,000 | – | 788,904 | +100.0% | 0.60% | – |
| ZTS | New | ZOETIS INCcall | $14,470,000 | – | 500,000 | +100.0% | 0.59% | – |
| DENDREON CORPnote 4.750% 6/1 | $14,308,000 | +0.9% | 14,740,000 | 0.0% | 0.58% | -20.5% | ||
| EHTH | New | EHEALTH INC | $13,767,000 | – | 271,000 | +100.0% | 0.56% | – |
| MEIP | Sell | MEI PHARMA INC | $12,962,000 | +29.0% | 1,164,575 | -7.2% | 0.53% | +1.5% |
| AGN | New | ALLERGAN INCcall | $12,410,000 | – | 100,000 | +100.0% | 0.51% | – |
| GNCA | New | GENOCEA BIOSCIENCES INC | $12,005,000 | – | 659,983 | +100.0% | 0.49% | – |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $11,976,000 | +122.3% | 565,180 | +88.4% | 0.49% | +75.3% |
| New | ENDOLOGIX INCnote 2.250%12/1 | $11,930,000 | – | 12,450,000 | +100.0% | 0.49% | – | |
| ANIP | New | ANI PHARMACEUTICALS INC | $11,649,000 | – | 371,572 | +100.0% | 0.48% | – |
| FMI | Sell | FOUNDATION MEDICINE INC | $11,100,000 | +34.7% | 342,921 | -0.9% | 0.45% | +6.1% |
| IMMU | New | IMMUNOMEDICS INC | $11,068,000 | – | 2,628,972 | +100.0% | 0.45% | – |
| AMAG | New | AMAG PHARMACEUTICALS INC | $10,351,000 | – | 534,930 | +100.0% | 0.42% | – |
| ALIM | New | ALIMERA SCIENCES INC | $10,346,000 | – | 1,311,290 | +100.0% | 0.42% | – |
| SPPI | Sell | SPECTRUM PHARMACEUTICALS INC | $9,921,000 | -52.5% | 1,265,375 | -46.4% | 0.40% | -62.6% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $9,606,000 | +45.5% | 907,920 | +4.5% | 0.39% | +14.6% |
| New | ACCURAY INCnote 3.500% 2/0 | $9,546,000 | – | 5,000,000 | +100.0% | 0.39% | – | |
| IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $9,480,000 | -27.0% | 206,128 | -24.2% | 0.39% | -42.4% |
| ZLTQ | New | ZELTIQ AESTHETICS INC | $9,482,000 | – | 483,520 | +100.0% | 0.39% | – |
| BLUE | Sell | BLUEBIRD BIO INC | $9,425,000 | +6.1% | 414,474 | -2.1% | 0.38% | -16.3% |
| ELGX | New | ENDOLOGIX INC | $8,796,000 | – | 683,458 | +100.0% | 0.36% | – |
| PTCT | Sell | PTC THERAPEUTICS INC | $8,300,000 | -10.3% | 317,530 | -41.7% | 0.34% | -29.2% |
| CNCE | New | CONCERT PHARMACEUTICALS INC | $8,307,000 | – | 617,649 | +100.0% | 0.34% | – |
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $8,153,000 | +4.1% | 501,709 | -20.5% | 0.33% | -18.0% |
| NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $8,076,000 | -25.0% | 391,105 | -37.4% | 0.33% | -40.9% |
| CSU | Sell | CAPITAL SR LIVING CORP | $8,007,000 | -76.5% | 308,088 | -78.3% | 0.33% | -81.4% |
| DSCO | DISCOVERY LABORATORIES INC N | $7,868,000 | -4.4% | 3,659,700 | 0.0% | 0.32% | -24.8% | |
| CNC | Sell | CENTENE CORP DEL | $7,768,000 | -57.9% | 124,795 | -60.1% | 0.32% | -66.8% |
| ARNA | ARENA PHARMACEUTICALS INC | $7,664,000 | +7.7% | 1,216,579 | 0.0% | 0.31% | -15.2% | |
| KBIO | New | KALOBIOS PHARMACEUTICALS INC | $7,552,000 | – | 2,786,783 | +100.0% | 0.31% | – |
| Sell | SEQUENOM INCnote 5.000%10/0 | $7,466,000 | -48.5% | 8,377,000 | -50.4% | 0.30% | -59.4% | |
| CASM | CAS MED SYS INC | $6,944,000 | +27.6% | 3,200,000 | 0.0% | 0.28% | +0.4% | |
| AUXL | New | AUXILIUM PHARMACEUTICALS INCput | $6,795,000 | – | 250,000 | +100.0% | 0.28% | – |
| AMED | New | AMEDISYS INC | $6,537,000 | – | 439,000 | +100.0% | 0.27% | – |
| ALERE INCnote 3.000% 5/1 | $6,278,000 | -2.5% | 5,750,000 | 0.0% | 0.26% | -23.4% | ||
| BAX | Sell | BAXTER INTL INC | $6,254,000 | -12.3% | 85,000 | -17.1% | 0.26% | -30.9% |
| ATEC | ALPHATEC HOLDINGS INC | $5,974,000 | -25.4% | 3,982,738 | 0.0% | 0.24% | -41.2% | |
| INGN | New | INOGEN INC | $5,899,000 | – | 357,269 | +100.0% | 0.24% | – |
| STRM | Buy | STREAMLINE HEALTH SOLUTIONS | $5,735,000 | +152.8% | 1,140,100 | +250.8% | 0.23% | +98.3% |
| ANTH | ANTHERA PHARMACEUTICALS INC | $5,668,000 | +9.1% | 1,691,857 | 0.0% | 0.23% | -14.1% | |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $5,552,000 | – | 78,500 | +100.0% | 0.23% | – |
| QURE | New | UNIQURE NV | $5,453,000 | – | 350,000 | +100.0% | 0.22% | – |
| XOMA | New | XOMA CORP DELcall | $5,210,000 | – | 1,000,000 | +100.0% | 0.21% | – |
| CGIX | Sell | CANCER GENETICS INC | $4,799,000 | -1.7% | 318,012 | -10.2% | 0.20% | -22.5% |
| LPDX | LIPOSCIENCE INC | $4,410,000 | -24.9% | 1,382,350 | 0.0% | 0.18% | -40.8% | |
| NSPH | Sell | NANOSPHERE INC | $4,300,000 | -60.4% | 2,000,000 | -57.9% | 0.18% | -68.7% |
| MNKD | New | MANNKIND CORPput | $4,020,000 | – | 1,000,000 | +100.0% | 0.16% | – |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $3,986,000 | +83.2% | 1,027,443 | +34.5% | 0.16% | +44.2% |
| DSCI | New | DERMA SCIENCES INC | $3,804,000 | – | 300,000 | +100.0% | 0.16% | – |
| RVNC | New | REVANCE THERAPEUTICS INC | $3,676,000 | – | 116,689 | +100.0% | 0.15% | – |
| EGRX | New | EAGLE PHARMACEUTICALS INC | $3,629,000 | – | 284,653 | +100.0% | 0.15% | – |
| BIIB | New | BIOGEN IDEC INC | $3,594,000 | – | 11,750 | +100.0% | 0.15% | – |
| AUXILIUM PHARMACEUTICALS INCnote 1.500% 7/1 | $3,278,000 | +18.3% | 2,500,000 | 0.0% | 0.13% | -6.9% | ||
| ITCI | New | INTRA CELLULAR THERAPIES INC | $3,117,000 | – | 171,437 | +100.0% | 0.13% | – |
| OXBT | New | OXYGEN BIOTHERAPEUTICS INC | $3,053,000 | – | 550,000 | +100.0% | 0.12% | – |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $3,012,000 | – | 455,741 | +100.0% | 0.12% | – |
| TRGT | TARGACEPT INC | $2,931,000 | +14.4% | 617,000 | 0.0% | 0.12% | -9.8% | |
| OCRX | Buy | OCERA THERAPEUTICS INC | $2,755,000 | +0.5% | 261,119 | +23.7% | 0.11% | -21.1% |
| ILMN | New | ILLUMINA INC | $2,631,000 | – | 17,697 | +100.0% | 0.11% | – |
| TNXP | New | TONIX PHARMACEUTICALS HLDG C | $2,545,000 | – | 244,524 | +100.0% | 0.10% | – |
| PTN | PALATIN TECHNOLOGIES INC | $2,460,000 | +67.6% | 2,000,000 | 0.0% | 0.10% | +31.6% | |
| TXMD | New | THERAPEUTICSMD INC | $2,373,000 | – | 376,049 | +100.0% | 0.10% | – |
| MRGE | New | MERGE HEALTHCARE INC | $2,341,000 | – | 959,580 | +100.0% | 0.10% | – |
| EXEL | New | EXELIXIS INCcall | $1,770,000 | – | 500,000 | +100.0% | 0.07% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $1,441,000 | – | 4,799 | +100.0% | 0.06% | – |
| EXEL | New | EXELIXIS INC | $1,416,000 | – | 400,000 | +100.0% | 0.06% | – |
| A | New | AGILENT TECHNOLOGIES INC | $1,398,000 | – | 25,000 | +100.0% | 0.06% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $1,256,000 | – | 77,994 | +100.0% | 0.05% | – |
| FURX | New | FURIEX PHARMACEUTICALS INC | $1,161,000 | – | 13,340 | +100.0% | 0.05% | – |
| HOLX | New | HOLOGIC INC | $914,000 | – | 42,500 | +100.0% | 0.04% | – |
| MYL | Sell | MYLAN INC | $855,000 | -94.8% | 17,500 | -95.4% | 0.04% | -95.9% |
| MDVN | New | MEDIVATION INC | $805,000 | – | 12,500 | +100.0% | 0.03% | – |
| AQXP | New | AQUINOX PHARMACEUTICALS INC | $794,000 | – | 62,387 | +100.0% | 0.03% | – |
| ELOS | New | SYNERON MEDICAL LTD | $430,000 | – | 34,518 | +100.0% | 0.02% | – |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $305,000 | – | 92,804 | +100.0% | 0.01% | – |
| NVDQ | Sell | NOVADAQ TECHNOLOGIES INC | $223,000 | -88.7% | 10,000 | -91.7% | 0.01% | -91.3% |
| OREX | Exit | OREXIGEN THERAPEUTICS INC | $0 | – | -21,690 | -100.0% | -0.01% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -5,000 | -100.0% | -0.01% | – |
| BONE | Exit | BACTERIN INTL HLDGS INC | $0 | – | -391,796 | -100.0% | -0.01% | – |
| IMRSQ | Exit | IMRIS INC | $0 | – | -192,051 | -100.0% | -0.02% | – |
| SEM | Exit | SELECT MED HLDGS CORP | $0 | – | -29,400 | -100.0% | -0.02% | – |
| BEAT | Exit | BIOTELEMETRY INC | $0 | – | -55,000 | -100.0% | -0.02% | – |
| HCA | Exit | HCA HOLDINGS INC | $0 | – | -10,000 | -100.0% | -0.02% | – |
| BIOS | Exit | BIOSCRIP INC | $0 | – | -70,022 | -100.0% | -0.03% | – |
| MSTX | Exit | MAST THERAPEUTICS INC | $0 | – | -1,466,249 | -100.0% | -0.04% | – |
| ARTC | Exit | ARTHROCARE CORP | $0 | – | -20,000 | -100.0% | -0.04% | – |
| AMGN | Exit | AMGEN INC | $0 | – | -10,000 | -100.0% | -0.06% | – |
| SNSS | Exit | SUNESIS PHARMACEUTICALS INCcall | $0 | – | -250,000 | -100.0% | -0.06% | – |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -111,967 | -100.0% | -0.06% | – |
| HMSY | Exit | HMS HLDGS CORP | $0 | – | -57,800 | -100.0% | -0.07% | – |
| ARWR | Exit | ARROWHEAD RESH CORP | $0 | – | -142,017 | -100.0% | -0.08% | – |
| Exit | ALBANY MOLECULAR RESH INCnote 2.250%11/1 | $0 | – | -2,575,000 | -100.0% | -0.12% | – | |
| KIN | Exit | KINDRED BIOSCIENCES INC | $0 | – | -225,000 | -100.0% | -0.13% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INCcall | $0 | – | -200,000 | -100.0% | -0.14% | – |
| LCAV | Exit | LCA-VISION INC | $0 | – | -730,856 | -100.0% | -0.15% | – |
| CEMP | Exit | CEMPRA INC | $0 | – | -309,655 | -100.0% | -0.20% | – |
| BINDQ | Exit | BIND THERAPEUTICS INC | $0 | – | -256,384 | -100.0% | -0.20% | – |
| SSH | Exit | SUNSHINE HEART INC | $0 | – | -432,000 | -100.0% | -0.22% | – |
| GERN | Exit | GERON CORP | $0 | – | -1,000,000 | -100.0% | -0.25% | – |
| MYL | Exit | MYLAN INCcall | $0 | – | -150,000 | -100.0% | -0.34% | – |
| AIRM | Exit | AIR METHODS CORPcall | $0 | – | -125,000 | -100.0% | -0.38% | – |
| Exit | ACCURAY INCnote 3.500% 2/0 | $0 | – | -5,000,000 | -100.0% | -0.45% | – | |
| DEPO | Exit | DEPOMED INC | $0 | – | -1,260,661 | -100.0% | -0.69% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -528,705 | -100.0% | -0.73% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -350,000 | -100.0% | -0.73% | – |
| Exit | BROOKDALE SR LIVING INCnote 2.750% 6/1 | $0 | – | -15,500,000 | -100.0% | -0.96% | – | |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -1,136,645 | -100.0% | -1.04% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -327,000 | -100.0% | -1.16% | – |
| XOMA | Exit | XOMA CORP DEL | $0 | – | -3,806,868 | -100.0% | -1.33% | – |
| CBST | Exit | CUBIST PHARMACEUTICALS INC | $0 | – | -386,282 | -100.0% | -1.38% | – |
| Exit | EXELIXIS INCnote 4.250% 8/1 | $0 | – | -25,050,000 | -100.0% | -1.59% | – | |
| GMED | Exit | GLOBUS MED INCcl a | $0 | – | -1,694,472 | -100.0% | -1.77% | – |
| HUM | Exit | HUMANA INC | $0 | – | -414,670 | -100.0% | -2.22% | – |
| Exit | NUVASIVE INCnote 2.750% 7/0 | $0 | – | -42,136,000 | -100.0% | -2.36% | – | |
| CBST | Exit | CUBIST PHARMACEUTICALS INCcall | $0 | – | -1,000,000 | -100.0% | -3.57% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.